$ENZN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ENZON PHARMACEUTICALS, INC..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in ENZON PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ENZON PHARMACEUTICALS, INC. for free.

Page: < prev 1 2 3 4 5 6 ... 6 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 29 2012	ENZN	ENZON PHARMACEUTIC ...	HEBARD GEORGE	Director	Grant	A	0.00	13,737	0	13,737	0 to 13.7 K
Jan 19 2012	ENZN	ENZON PHARMACEUTIC ...	Conover Charles	SVP, R&D Program Ma ...	Option Exercise	A	6.69	25,000	167,250	25,000
Jan 19 2012	ENZN	ENZON PHARMACEUTIC ...	Conover Charles	SVP, R&D Program Ma ...	Grant	A	0.00	10,000	0	82,213	72.2 K to 82.2 K (+13.85 %)
Jan 19 2012	ENZN	ENZON PHARMACEUTIC ...	Rackear Andrew D.	VP and General Coun ...	Option Exercise	A	6.69	25,000	167,250	25,000
Jan 19 2012	ENZN	ENZON PHARMACEUTIC ...	Rackear Andrew D.	VP and General Coun ...	Grant	A	0.00	10,000	0	58,334	48.3 K to 58.3 K (+20.69 %)
Jan 19 2012	ENZN	ENZON PHARMACEUTIC ...	Greenberger Lee M	VP, Research	Option Exercise	A	6.69	12,000	80,280	12,000
Jan 19 2012	ENZN	ENZON PHARMACEUTIC ...	Greenberger Lee M	VP, Research	Grant	A	0.00	3,500	0	36,146	32.6 K to 36.1 K (+10.72 %)
Jan 19 2012	ENZN	ENZON PHARMACEUTIC ...	Stancic Ana	Executive VP, COO, ...	Grant	A	0.00	45,000	0	70,000	25 K to 70 K (+180.00 %)
Jan 19 2012	ENZN	ENZON PHARMACEUTIC ...	Stancic Ana	Executive VP, COO, ...	Sell	D	0.00	45,000	0	15,000	60 K to 15 K (-75.00 %)
Jan 05 2012	ENZN	ENZON PHARMACEUTIC ...	Deuel Thomas	Director	Option Exercise	A	6.81	10,994	74,869	10,994
Jan 05 2012	ENZN	ENZON PHARMACEUTIC ...	Mulligan Richard	Director	Option Exercise	A	6.81	19,240	131,024	19,240
Jan 05 2012	ENZN	ENZON PHARMACEUTIC ...	SALISBURY ROBERT C	Director	Option Exercise	A	6.81	10,994	74,869	10,994
Jan 05 2012	ENZN	ENZON PHARMACEUTIC ...	Young Richard A	Director	Option Exercise	A	6.81	10,994	74,869	10,994
Jan 05 2012	ENZN	ENZON PHARMACEUTIC ...	LEBUHN ROBERT	Director	Option Exercise	A	6.81	10,994	74,869	10,994
Jan 05 2012	ENZN	ENZON PHARMACEUTIC ...	DENNER ALEXANDER J	Director	Option Exercise	A	6.81	21,988	149,738	21,988
Dec 20 2011	ENZN	ENZON PHARMACEUTIC ...	Daly Timothy	VP, Controller and ...	Option Exercise	A	6.50	20,000	130,000	20,000
Nov 21 2011	ENZN	ENZON PHARMACEUTIC ...	Stancic Ana	Executive VP, COO, ...	Option Exercise	A	6.37	125,000	796,250	155,000
Nov 21 2011	ENZN	ENZON PHARMACEUTIC ...	Stancic Ana	Executive VP, COO, ...	Grant	A	0.00	45,000	0	70,000	25 K to 70 K (+180.00 %)
Nov 10 2011	ENZN	ENZON PHARMACEUTIC ...	Rackear Andrew D.	VP and General Coun ...	Sell	S	6.68	3,766	25,157	48,334	52.1 K to 48.3 K (-7.23 %)
Nov 10 2011	ENZN	ENZON PHARMACEUTIC ...	Buchbinder Aby	VP, Clinical Develo ...	Sell	S	7.06	2,700	19,062	54,015	56.7 K to 54 K (-4.76 %)
Sep 19 2011	ENZN	ENZON PHARMACEUTIC ...	Greenberger Lee M	VP, Research	Payment of Exercise	F	8.33	591	4,923	32,646	33.2 K to 32.6 K (-1.78 %)
Sep 19 2011	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	COO and Princ. Exec ...	Payment of Exercise	F	8.33	886	7,380	204,633	205.5 K to 204.6 K (-0.43 %)
Sep 19 2011	ENZN	ENZON PHARMACEUTIC ...	Rackear Andrew D.	VP and General Coun ...	Payment of Exercise	F	8.33	2,067	17,218	52,100	54.2 K to 52.1 K (-3.82 %)
Sep 19 2011	ENZN	ENZON PHARMACEUTIC ...	Buchbinder Aby	VP, Clinical Develo ...	Payment of Exercise	F	8.33	2,952	24,590	56,715	59.7 K to 56.7 K (-4.95 %)
Aug 16 2011	ENZN	ENZON PHARMACEUTIC ...	Buchbinder Aby	VP, Clinical Develo ...	Grant	A	0.00	8,000	0	59,667	51.7 K to 59.7 K (+15.48 %)
Aug 16 2011	ENZN	ENZON PHARMACEUTIC ...	Rackear Andrew D.	VP and General Coun ...	Grant	A	0.00	10,000	0	54,167	44.2 K to 54.2 K (+22.64 %)
Aug 16 2011	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	COO and Princ. Exec ...	Grant	A	0.00	35,000	0	204,633	169.6 K to 204.6 K (+20.63 %)
Jul 06 2011	ENZN	ENZON PHARMACEUTIC ...	DENNER ALEXANDER J	Director	Grant	A	0.00	14,764	0	39,282	24.5 K to 39.3 K (+60.22 %)
Jul 06 2011	ENZN	ENZON PHARMACEUTIC ...	Deuel Thomas	Director	Grant	A	0.00	7,382	0	21,562	14.2 K to 21.6 K (+52.06 %)
Jul 06 2011	ENZN	ENZON PHARMACEUTIC ...	Mulligan Richard	Director	Grant	A	0.00	12,919	0	30,394	17.5 K to 30.4 K (+73.93 %)
Jul 06 2011	ENZN	ENZON PHARMACEUTIC ...	Young Richard A	Director	Grant	A	0.00	7,382	0	21,562	14.2 K to 21.6 K (+52.06 %)
Jul 06 2011	ENZN	ENZON PHARMACEUTIC ...	SALISBURY ROBERT C	Director	Grant	A	0.00	7,382	0	57,038	49.7 K to 57 K (+14.87 %)
Jul 06 2011	ENZN	ENZON PHARMACEUTIC ...	LEBUHN ROBERT	Director	Grant	A	0.00	7,382	0	95,199	87.8 K to 95.2 K (+8.41 %)
Jul 06 2011	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Payment of Exercise	F	10.16	1,969	20,005	109,314	111.3 K to 109.3 K (-1.77 %)
Jun 09 2011	ENZN	ENZON PHARMACEUTIC ...	Stancic Ana	Senior VP, Finance ...	Option Exercise	A	10.22	30,000	306,600	30,000
Jun 09 2011	ENZN	ENZON PHARMACEUTIC ...	Stancic Ana	Senior VP, Finance ...	Grant	A	0.00	25,000	0	25,000	0 to 25 K
Jun 02 2011	ENZN	ENZON PHARMACEUTIC ...	LEBUHN ROBERT	Director	Sell	S	10.57	8,702	91,980	0	8.7 K to 0 (-100.00 %)
Apr 05 2011	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	COO and Princ. Exec ...	Option Exercise	M	0.00	16,800	0	0
Apr 05 2011	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	COO and Princ. Exec ...	Payment of Exercise	F	11.02	5,951	65,580	169,633	175.6 K to 169.6 K (-3.39 %)
Apr 05 2011	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	COO and Princ. Exec ...	Buy	M	0.00	16,800	0	175,584	158.8 K to 175.6 K (+10.58 %)
Apr 05 2011	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Option Exercise	M	0.00	16,800	0	0
Apr 05 2011	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Payment of Exercise	F	11.02	9,380	103,368	138,476	147.9 K to 138.5 K (-6.34 %)
Apr 05 2011	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Buy	M	0.00	26,480	0	147,856	121.4 K to 147.9 K (+21.82 %)
Apr 05 2011	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Option Exercise	M	0.00	12,760	0	0
Apr 05 2011	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Payment of Exercise	F	11.02	3,767	41,512	111,283	115.1 K to 111.3 K (-3.27 %)
Apr 05 2011	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Buy	M	0.00	12,760	0	115,050	102.3 K to 115.1 K (+12.47 %)
Apr 01 2011	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	COO and Princ. Exec ...	Payment of Exercise	F	10.76	886	9,533	158,784	159.7 K to 158.8 K (-0.55 %)
Apr 01 2011	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	COO and Princ. Exec ...	Buy	J	0.00	2,500	0	159,670	157.2 K to 159.7 K (+1.59 %)
Apr 01 2011	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Payment of Exercise	F	10.76	886	9,533	121,376	122.3 K to 121.4 K (-0.72 %)
Apr 01 2011	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Buy	J	0.00	2,500	0	122,262	119.8 K to 122.3 K (+2.09 %)
Apr 01 2011	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Payment of Exercise	F	10.76	394	4,239	102,290	102.7 K to 102.3 K (-0.38 %)
Apr 01 2011	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Buy	J	0.00	1,333	0	102,684	101.4 K to 102.7 K (+1.32 %)
Jan 28 2011	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Payment of Exercise	F	11.63	6,070	70,594	122,262	128.3 K to 122.3 K (-4.73 %)
Jan 28 2011	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Buy	J	0.00	16,465	0	128,332	111.9 K to 128.3 K (+14.72 %)
Jan 28 2011	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Payment of Exercise	F	12.15	6,793	82,535	128,332	135.1 K to 128.3 K (-5.03 %)
Jan 28 2011	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Buy	J	0.00	18,333	0	135,125	116.8 K to 135.1 K (+15.70 %)
Mar 01 2011	ENZN	ENZON PHARMACEUTIC ...	Ogden Mark L	Acting VP of Fin & ...	Buy	P	10.65	2,000	21,298	4,000	2 K to 4 K (+100.00 %)
Feb 24 2011	ENZN	ENZON PHARMACEUTIC ...	LEBUHN ROBERT	Director	Sell	S	10.88	10,000	108,817	96,519	106.5 K to 96.5 K (-9.39 %)
Jan 28 2011	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Payment of Exercise	F	11.63	2,533	29,459	102,684	105.2 K to 102.7 K (-2.41 %)
Jan 28 2011	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Buy	J	0.00	7,599	0	105,217	97.6 K to 105.2 K (+7.78 %)
Jan 28 2011	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Payment of Exercise	F	12.15	1,124	13,657	105,217	106.3 K to 105.2 K (-1.06 %)
Jan 28 2011	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Buy	J	0.00	3,333	0	106,341	103 K to 106.3 K (+3.24 %)
Jan 28 2011	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	COO and Princ. Exec ...	Payment of Exercise	F	11.63	4,744	55,173	159,670	164.4 K to 159.7 K (-2.89 %)
Jan 28 2011	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	COO and Princ. Exec ...	Buy	J	0.00	12,665	0	164,414	151.7 K to 164.4 K (+8.35 %)
Jan 28 2011	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	COO and Princ. Exec ...	Payment of Exercise	F	12.15	6,802	82,644	164,414	171.2 K to 164.4 K (-3.97 %)
Jan 28 2011	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	COO and Princ. Exec ...	Buy	J	0.00	18,333	0	171,216	152.9 K to 171.2 K (+11.99 %)
Jan 05 2011	ENZN	ENZON PHARMACEUTIC ...	Deuel Thomas	Director	Option Exercise	A	12.40	16,996	210,750	16,996
Jan 05 2011	ENZN	ENZON PHARMACEUTIC ...	CLASSON ROLF A	Director	Option Exercise	A	12.40	16,996	210,750	16,996
Jan 05 2011	ENZN	ENZON PHARMACEUTIC ...	SALISBURY ROBERT C	Director	Option Exercise	A	12.40	16,996	210,750	16,996
Jan 05 2011	ENZN	ENZON PHARMACEUTIC ...	Young Richard A	Director	Option Exercise	A	12.40	16,996	210,750	16,996
Jan 05 2011	ENZN	ENZON PHARMACEUTIC ...	Mulligan Richard	Director	Option Exercise	A	12.40	16,996	210,750	16,996
Jan 05 2011	ENZN	ENZON PHARMACEUTIC ...	LEBUHN ROBERT	Director	Option Exercise	A	12.40	16,996	210,750	16,996
Jan 05 2011	ENZN	ENZON PHARMACEUTIC ...	DENNER ALEXANDER J	Director	Option Exercise	A	12.40	33,991	421,488	33,991
Nov 24 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Option Exercise	M	0.00	3,000	0	0
Nov 24 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Payment of Exercise	F	10.92	1,063	11,608	137,125	138.2 K to 137.1 K (-0.77 %)
Nov 24 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Buy	M	0.00	3,000	0	138,188	135.2 K to 138.2 K (+2.22 %)
Nov 24 2010	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	COO and Princ. Exec ...	Option Exercise	M	0.00	4,000	0	0
Nov 24 2010	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	COO and Princ. Exec ...	Payment of Exercise	F	10.92	1,417	15,474	180,216	181.6 K to 180.2 K (-0.78 %)
Nov 24 2010	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	COO and Princ. Exec ...	Buy	M	0.00	4,000	0	181,633	177.6 K to 181.6 K (+2.25 %)
Nov 24 2010	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Option Exercise	M	0.00	4,000	0	0
Nov 24 2010	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Payment of Exercise	F	10.92	1,181	12,897	105,556	106.7 K to 105.6 K (-1.11 %)
Nov 24 2010	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Buy	M	0.00	4,000	0	106,737	102.7 K to 106.7 K (+3.89 %)
Sep 24 2010	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	COO and Principal E ...	Grant	A	0.00	15,000	0	177,633	162.6 K to 177.6 K (+9.22 %)
Sep 24 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, President of R ...	Grant	A	0.00	15,000	0	135,188	120.2 K to 135.2 K (+12.48 %)
Sep 24 2010	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Grant	A	0.00	8,000	0	102,737	94.7 K to 102.7 K (+8.44 %)
Sep 17 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Option Exercise	M	7.40	79,200	586,080	66,500
Sep 17 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Option Exercise	M	7.14	162,800	1,162,392	0
Sep 17 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Option Exercise	M	7.14	2,000	14,280	162,800
Sep 17 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Option Exercise	M	7.14	35,200	251,328	164,800
Sep 17 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Option Exercise	M	6.97	35,000	243,950	0
Sep 17 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Sell	S	10.63	200,000	2,126,660	120,188	320.2 K to 120.2 K (-62.46 %)
Sep 17 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Buy	M	7.40	79,200	586,080	320,188	241 K to 320.2 K (+32.86 %)
Sep 17 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Buy	M	7.14	162,800	1,162,392	240,988	78.2 K to 241 K (+208.22 %)
Sep 17 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Sell	S	10.67	1,700	18,132	78,188	79.9 K to 78.2 K (-2.13 %)
Sep 17 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Buy	M	7.14	2,000	14,280	79,888	77.9 K to 79.9 K (+2.57 %)
Sep 17 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Sell	S	10.81	57,200	618,200	77,888	135.1 K to 77.9 K (-42.34 %)
Sep 17 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Buy	M	7.14	35,200	251,328	135,088	99.9 K to 135.1 K (+35.24 %)
Sep 17 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Buy	M	6.97	35,000	243,950	99,888	64.9 K to 99.9 K (+53.94 %)
Sep 07 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Option Exercise	M	0.00	20,000	0	0
Sep 07 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Payment of Exercise	F	10.58	7,084	74,949	64,888	72 K to 64.9 K (-9.84 %)
Sep 07 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	EVP, R&D, CSO	Buy	M	0.00	20,000	0	71,972	52 K to 72 K (+38.48 %)
Aug 27 2010	ENZN	ENZON PHARMACEUTIC ...	LEBUHN ROBERT	Director	Sell	S	10.49	5,000	52,425	106,519	111.5 K to 106.5 K (-4.48 %)
Aug 27 2010	ENZN	ENZON PHARMACEUTIC ...	LEBUHN ROBERT	Director	Sell	S	10.51	400	4,204	111,519	111.9 K to 111.5 K (-0.36 %)
Aug 27 2010	ENZN	ENZON PHARMACEUTIC ...	LEBUHN ROBERT	Director	Sell	S	10.50	4,600	48,300	111,919	116.5 K to 111.9 K (-3.95 %)
Jul 06 2010	ENZN	ENZON PHARMACEUTIC ...	DENNER ALEXANDER J	Director	Grant	A	0.00	14,086	0	24,518	10.4 K to 24.5 K (+135.03 %)
Jul 06 2010	ENZN	ENZON PHARMACEUTIC ...	Mulligan Richard	Director	Grant	A	0.00	7,043	0	17,475	10.4 K to 17.5 K (+67.51 %)
Jul 06 2010	ENZN	ENZON PHARMACEUTIC ...	Deuel Thomas	Director	Grant	A	0.00	7,043	0	14,180	7.1 K to 14.2 K (+98.68 %)
Jul 06 2010	ENZN	ENZON PHARMACEUTIC ...	LEBUHN ROBERT	Director	Option Exercise	M	0.00	3,173	0	0
Jul 06 2010	ENZN	ENZON PHARMACEUTIC ...	LEBUHN ROBERT	Director	Buy	M	0.00	3,173	0	116,519	113.3 K to 116.5 K (+2.80 %)
Jul 06 2010	ENZN	ENZON PHARMACEUTIC ...	LEBUHN ROBERT	Director	Grant	A	0.00	7,043	0	113,346	106.3 K to 113.3 K (+6.63 %)
Jul 06 2010	ENZN	ENZON PHARMACEUTIC ...	CLASSON ROLF A	Director	Option Exercise	M	0.00	3,173	0	0
Jul 06 2010	ENZN	ENZON PHARMACEUTIC ...	CLASSON ROLF A	Director	Buy	M	0.00	3,173	0	55,320	52.1 K to 55.3 K (+6.08 %)
Jul 06 2010	ENZN	ENZON PHARMACEUTIC ...	CLASSON ROLF A	Director	Grant	A	0.00	7,043	0	52,147	45.1 K to 52.1 K (+15.62 %)
Jul 06 2010	ENZN	ENZON PHARMACEUTIC ...	Young Richard A	Director	Grant	A	0.00	7,043	0	14,180	7.1 K to 14.2 K (+98.68 %)
Jul 06 2010	ENZN	ENZON PHARMACEUTIC ...	SALISBURY ROBERT C	Director	Option Exercise	M	0.00	3,173	0	0
Jul 06 2010	ENZN	ENZON PHARMACEUTIC ...	SALISBURY ROBERT C	Director	Buy	M	0.00	3,173	0	49,656	46.5 K to 49.7 K (+6.83 %)
Jul 06 2010	ENZN	ENZON PHARMACEUTIC ...	SALISBURY ROBERT C	Director	Grant	A	0.00	7,043	0	46,483	39.4 K to 46.5 K (+17.86 %)
Jul 06 2010	ENZN	ENZON PHARMACEUTIC ...	MICATI VICTOR P	Director	Option Exercise	M	0.00	3,173	0	0
Jul 06 2010	ENZN	ENZON PHARMACEUTIC ...	MICATI VICTOR P	Director	Buy	M	0.00	3,173	0	50,625	47.5 K to 50.6 K (+6.69 %)
Jul 06 2010	ENZN	ENZON PHARMACEUTIC ...	MICATI VICTOR P	Director	Grant	A	0.00	7,043	0	47,452	40.4 K to 47.5 K (+17.43 %)
Jun 22 2010	ENZN	ENZON PHARMACEUTIC ...	TOOMAN CRAIG A	Exec VP Finance, CF ...	Option Exercise	M	8.59	140,800	1,209,472	159,200
Jun 22 2010	ENZN	ENZON PHARMACEUTIC ...	TOOMAN CRAIG A	Exec VP Finance, CF ...	Sell	S	11.25	123,100	1,385,220	160,480	283.6 K to 160.5 K (-43.41 %)
Jun 22 2010	ENZN	ENZON PHARMACEUTIC ...	TOOMAN CRAIG A	Exec VP Finance, CF ...	Buy	M	8.59	140,800	1,209,472	283,580	142.8 K to 283.6 K (+98.61 %)
May 14 2010	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	Chief Operating Off ...	Option Exercise	M	0.00	6,000	0	0
May 14 2010	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	Chief Operating Off ...	Payment of Exercise	F	10.90	2,126	23,173	162,633	164.8 K to 162.6 K (-1.29 %)
May 14 2010	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	Chief Operating Off ...	Buy	M	0.00	6,000	0	164,759	158.8 K to 164.8 K (+3.78 %)
May 14 2010	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Option Exercise	M	0.00	6,000	0	0
May 14 2010	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Payment of Exercise	F	10.90	1,772	19,315	94,737	96.5 K to 94.7 K (-1.84 %)
May 14 2010	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Buy	M	0.00	6,000	0	96,509	90.5 K to 96.5 K (+6.63 %)
May 14 2010	ENZN	ENZON PHARMACEUTIC ...	TOOMAN CRAIG A	Exec VP Finance, CF ...	Option Exercise	M	0.00	6,000	0	0
May 14 2010	ENZN	ENZON PHARMACEUTIC ...	TOOMAN CRAIG A	Exec VP Finance, CF ...	Payment of Exercise	F	10.90	2,126	23,173	142,780	144.9 K to 142.8 K (-1.47 %)
May 14 2010	ENZN	ENZON PHARMACEUTIC ...	TOOMAN CRAIG A	Exec VP Finance, CF ...	Buy	M	0.00	6,000	0	144,906	138.9 K to 144.9 K (+4.32 %)
Apr 27 2010	ENZN	ENZON PHARMACEUTIC ...	Young Richard A	Director	Option Exercise	A	10.51	17,673	185,743	17,673
Apr 27 2010	ENZN	ENZON PHARMACEUTIC ...	Young Richard A	Director	Grant	A	0.00	7,137	0	7,137	0 to 7.1 K
Apr 27 2010	ENZN	ENZON PHARMACEUTIC ...	Deuel Thomas	Director	Option Exercise	A	10.51	17,673	185,743	17,673
Apr 27 2010	ENZN	ENZON PHARMACEUTIC ...	Deuel Thomas	Director	Grant	A	0.00	7,137	0	7,137	0 to 7.1 K
Apr 14 2010	ENZN	ENZON PHARMACEUTIC ...	TOOMAN CRAIG A	Exec. V.P. Finance, ...	Option Exercise	M	0.00	16,740	0	22,320
Apr 14 2010	ENZN	ENZON PHARMACEUTIC ...	TOOMAN CRAIG A	Exec. V.P. Finance, ...	Payment of Exercise	F	10.48	5,930	62,146	138,906	144.8 K to 138.9 K (-4.09 %)
Apr 14 2010	ENZN	ENZON PHARMACEUTIC ...	TOOMAN CRAIG A	Exec. V.P. Finance, ...	Buy	M	0.00	16,740	0	144,836	128.1 K to 144.8 K (+13.07 %)
Apr 13 2010	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	Chief Operating Off ...	Option Exercise	M	0.00	12,600	0	16,800
Apr 13 2010	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	Chief Operating Off ...	Payment of Exercise	F	10.48	4,463	46,772	158,759	163.2 K to 158.8 K (-2.73 %)
Apr 13 2010	ENZN	ENZON PHARMACEUTIC ...	del Campo Ralph	Chief Operating Off ...	Buy	M	0.00	12,600	0	163,222	150.6 K to 163.2 K (+8.37 %)
Apr 13 2010	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Option Exercise	M	0.00	9,570	0	12,760
Apr 13 2010	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Payment of Exercise	F	10.48	2,826	29,616	90,509	93.3 K to 90.5 K (-3.03 %)
Apr 13 2010	ENZN	ENZON PHARMACEUTIC ...	Davit Paul Stephen	Exec. Vice Pres. HR	Buy	M	0.00	9,570	0	93,335	83.8 K to 93.3 K (+11.42 %)
Apr 13 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	President of R&D	Option Exercise	M	0.00	19,860	0	26,480
Apr 13 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	President of R&D	Payment of Exercise	F	10.48	7,035	73,727	51,972	59 K to 52 K (-11.92 %)
Apr 13 2010	ENZN	ENZON PHARMACEUTIC ...	HORAK IVAN D	President of R&D	Buy	M	0.00	19,860	0	59,007	39.1 K to 59 K (+50.73 %)
Mar 10 2010	ENZN	ENZON PHARMACEUTIC ...	Levy Harold J	Director	Option Exercise	C	0.00	116,535	0	0
Mar 10 2010	ENZN	ENZON PHARMACEUTIC ...	Levy Harold J	Director	Buy	C	0.00	116,535	0	166,535	50 K to 166.5 K (+233.07 %)

Page: < prev 1 2 3 4 5 6 ... 6 next >